CAM
WST icon

Claret Asset Management’s West Pharmaceutical WST Stock Holding History

Claret Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
646
-400
-38% -$122K 0.03% 245
2026
Q1 		$262K Sell
1,046
-11
-1% -$2.74K 0.03% 234
2025
Q4 		$291K Sell
1,057
-3
-0.3% -$821 0.03% 190
2025
Q3 		$278K Sell
1,060
-15
-1% -$3.65K 0.03% 186
2025
Q2 		$235K Buy
+1,075
New +$230K 0.03% 259

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Claret Asset Management's WST Position: Q2 2026 in Review

Claret Asset Management reduced its West Pharmaceutical (WST) stake by 38% in Q2 2026, selling an estimated $122K and leaving 646 shares worth $232K. The position accounts for 0.03% of the portfolio, ranked #245.

Claret Asset Management first reported a position in WST in Q2 2025 and has held it in 5 quarters since. The position peaked at $291K in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Claret Asset Management held 646 shares of West Pharmaceutical worth $232K as of Q2 2026.
  • Claret Asset Management sold 400 West Pharmaceutical shares in Q2 2026, an estimated $122K.
  • West Pharmaceutical made up 0.03% of Claret Asset Management's portfolio in Q2 2026, its #245 holding.
  • Claret Asset Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Claret Asset Management's West Pharmaceutical position peaked at $291K in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.